{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:03:27Z","timestamp":1759341807481},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1684\/bdc.2011.1491","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:33Z","timestamp":1565726313000},"page":"263-275","source":"Crossref","is-referenced-by-count":3,"title":["Syndromes paran\u00e9oplasiques \u00e0 expression r\u00e9nale et atteintes r\u00e9nales des cancers"],"prefix":"10.1016","volume":"99","author":[{"given":"Juliette","family":"Thariat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Roca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Ravaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Lacout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Yves","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Thyss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Besancenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2011.1491_bib0005","unstructured":"Launay Vacher V. Prevalence. Bull Cancer 2011 (in press)."},{"key":"10.1684\/bdc.2011.1491_bib0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1523-1755.2003.00771.x","article-title":"Glomerulonephritis and malignancy: a population-based analysis","volume":"63","author":"Birkeland","year":"2003","journal-title":"Kidney Int"},{"key":"10.1684\/bdc.2011.1491_bib0015","article-title":"Renal toxicity of targeted therapies","author":"Thariat","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1491_bib0020","article-title":"Radiation-induced kidney disease","author":"Bouillet","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1491_bib0025","article-title":"Assessment of renal function","author":"Launay Vacher","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1491_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","article-title":"Paraneoplastic glomerulopathies: new insights into an old entity","volume":"56","author":"Ronco","year":"1999","journal-title":"Kidney Int"},{"key":"10.1684\/bdc.2011.1491_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","article-title":"Paraneoplastic glomerular diseases and malignancies","volume":"70","author":"Bacchetta","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1684\/bdc.2011.1491_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-7622-2-11","article-title":"The Bradford Hill considerations on causality: a counterfactual perspective","volume":"2","author":"Hofler","year":"2005","journal-title":"Emerg Themes Epidemiol"},{"key":"10.1684\/bdc.2011.1491_bib0045","first-page":"222","article-title":"Paraneoplastic syndromes and the kidney","volume":"21","author":"de Oliveira Filgueira","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1684\/bdc.2011.1491_bib0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000409763","article-title":"IgA mesangial nephropathy in neoplastic diseases","volume":"40","author":"Mustonen","year":"1984","journal-title":"Contrib Nephrol"},{"key":"10.1684\/bdc.2011.1491_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000166810","article-title":"Crescentic glomerulonephritis associated with nonrenal malignancies","volume":"4","author":"Biava","year":"1984","journal-title":"Am J Nephrol"},{"key":"10.1684\/bdc.2011.1491_bib0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000186877","article-title":"Minimal change nephrotic syndrome revealing solid tumors","volume":"61","author":"Meyrier","year":"1992","journal-title":"Nephron"},{"key":"10.1684\/bdc.2011.1491_bib0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0046-8177(83)80016-1","article-title":"Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature","volume":"14","author":"Vanatta","year":"1983","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2011.1491_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0002-9343(71)90205-1","article-title":"Acute nephrotic syndrome as a manifestation of active Hodgkin's disease. Report of four cases and review of the literature","volume":"50","author":"Plager","year":"1971","journal-title":"Am J Med"},{"key":"10.1684\/bdc.2011.1491_bib0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1491_bib0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2796.1995.tb00907.x","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease","volume":"238","author":"Sorensen","year":"1995","journal-title":"J Intern Med"},{"key":"10.1684\/bdc.2011.1491_bib0085","first-page":"121","article-title":"Renin-secreting tumours","volume":"2","author":"Amar","year":"2005","journal-title":"Encycl Med Chir : Endocrinologie"},{"key":"10.1684\/bdc.2011.1491_bib0090","first-page":"173","article-title":"Retroperitoneal fibrosis, an unrecognized inflammatory disease. Clinical observations and review of the literature","volume":"24","author":"Meier","year":"2003","journal-title":"Nephrologie"},{"key":"10.1684\/bdc.2011.1491_bib0095","first-page":"250","article-title":"The clinical significance of retroperitoneal fibrosis","volume":"81","author":"Koep","year":"1977","journal-title":"Surgery"},{"key":"10.1684\/bdc.2011.1491_bib0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000046589","article-title":"Thrombotic microangiopathy in the cancer patient","volume":"106","author":"Kwaan","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1684\/bdc.2011.1491_bib0105","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-11-0804","article-title":"Thrombotic microangiopathy with targeted cancer agents","author":"Blake-Haskins","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2011.1491_bib0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(84)90781-2","article-title":"Acute renal failure in patients with multiple myeloma","volume":"76","author":"Cohen","year":"1984","journal-title":"Am J Med"},{"key":"10.1684\/bdc.2011.1491_bib0115","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2010.30.8791","article-title":"Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group","volume":"28","author":"Dimopoulos","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1491_bib0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2215\/CJN.04590908","article-title":"Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis","volume":"4","author":"Hutchison","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1684\/bdc.2011.1491_bib0125","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1491_bib0130","article-title":"Imaging of the kidney","author":"Renard-Penna","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1491_bib0135","article-title":"Renal toxicity of contrast agents","author":"Amet","year":"2011","journal-title":"Bull Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:33:59Z","timestamp":1602491639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115304756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0007455115304756"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2011.1491","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}